Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.
Fetuses with enlarged ventricles may be less likely than other fetuses to benefit from surgery in the womb to treat spina bifida, according to a study co-authored by researchers at UCSF Benioff Children’s Hospital San Francisco.
Heart and lung transplant recipients are living longer than ever before, thanks to rapid advances in technology, medications and surgical procedures. That progress was cause for celebration last month at UCSF, where 400 patients and families gathered.
In a perspective published by the New England Journal of Medicine, UCSF's Elizabeth Watkins shares a historical perspective of pharmaceutical advertising and proposes a new approach for educating consumers.
Privately insured pregnant women are less likely to have C-sections when their regular care includes midwives and 24-hour obstetrician coverage, according to a study by researchers at UCSF and Marin General Hospital.
Researchers at UCSF are leading a five-year, $10 million research project dedicated to pediatric cancer, funded by the first grant of its kind to focus on a molecular pathway that underlies many cancers.
As early humans took an evolutionary step away from apes, what this last common ancestor with apes looked like has remained unclear. A new study led by researchers at UCSF shows that important clues lie in the shoulder.
Rapid next-generation genomic sequencing helped identify a mysterious brain-eating amoeba that killed a patient, and a new UCSF center aims to make this test an affordable and available tool for more hospitals.
A rare, deadly form of skin cancer known as desmoplasmic melanoma may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UCSF scientists.
Genetic vulnerabilities associated with childhood cancers may make children undergoing radiation therapy more susceptible than adults to secondary cancers, according to novel insights from researchers at UCSF.
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.